Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

    NEXT STORY
    Global Sports Medicine Markets to 2024 – An $8.8 Billion Opportunity, Rising at a CAGR of 6%
    PREV STORY
    Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER

    Jacques Theurillat to be proposed to Annual Shareholder Meeting for appointment to Board Marc ...

    author_avatar
    NASDAQ Market News

    Orion’s and Bayer’s darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial

    author_avatar
    NASDAQ Market News

    Adaptive Biotechnologies Announces Pricing of Initial Public Offering

    author_avatar
    NASDAQ Market News